1. Comparison of the induction of apoptosis in human leukemic cell lines by 2′,2′-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside
- Author
-
David Y. Bouffard and Richard L. Momparler
- Subjects
Antimetabolites, Antineoplastic ,Cancer Research ,Programmed cell death ,Leukemia, T-Cell ,Gene Expression ,Apoptosis ,HL-60 Cells ,DNA laddering ,Biology ,Deoxycytidine ,Alkaloids ,Genes, jun ,Tumor Cells, Cultured ,medicine ,Humans ,Staurosporine ,Enzyme Inhibitors ,Protein Kinase C ,c-jun ,Cytarabine ,Genes, fos ,Drug Synergism ,DNA, Neoplasm ,Hematology ,Blotting, Northern ,Gemcitabine ,Oncology ,Biochemistry ,Cell culture ,Cancer research ,DNA fragmentation ,DNA Damage ,medicine.drug - Abstract
The induction of DNA fragmentation by cytosine arabinoside (araC) and 2',2'-difluorodeoxycytidine (dFdC, gemcitabine) was compared in human leukemic cell lines. For both araC and dFdC this process was time- and concentration-dependent and resulted in loss of clonogenic survival of HL-60 myeloid leukemic cells. There was a marked difference in the potency between these two analogs in inducing apoptosis. A 6 h exposure to 5 microM araC was required to produce DNA laddering in HL-60 cells, whereas dFdC at a concentration 100-fold less (0.05 microM) was sufficient to produce similar results. Pre-incubation of HL-60 cells with staurosporine, a non-specific protein kinase C inhibitor, increased the level of apoptosis induced by a 3 h exposure to araC or dFdC, suggesting the possible involvement of this family of enzymes in this process. Also, dFdC was able to increase the expression of both c-jun and c-fos in Molt-3 leukemic cells with a concentration known to induce apoptosis in this cell line.
- Published
- 1995
- Full Text
- View/download PDF